OneAscent Financial Services’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-11,872
| Closed | -$210K | – | 205 |
|
2022
Q2 | $210K | Sell |
11,872
-205
| -2% | -$3.63K | 0.1% | 200 |
|
2022
Q1 | $246K | Buy |
12,077
+303
| +3% | +$6.17K | 0.18% | 103 |
|
2021
Q4 | $220K | Buy |
11,774
+612
| +5% | +$11.4K | 0.42% | 111 |
|
2021
Q3 | $220K | Buy |
+11,162
| New | +$220K | 0.29% | 81 |
|
2021
Q1 | $201K | Buy |
+8,477
| New | +$201K | 0.2% | 138 |
|
2020
Q4 | – | Sell |
-16,497
| Closed | -$343K | – | 139 |
|
2020
Q3 | $343K | Buy |
16,497
+4,659
| +39% | +$96.9K | 0.18% | 121 |
|
2020
Q2 | $207K | Buy |
11,838
+715
| +6% | +$12.5K | 0.14% | 160 |
|
2020
Q1 | $182K | Sell |
11,123
-9,583
| -46% | -$157K | 0.14% | 135 |
|
2019
Q4 | $426K | Buy |
+20,706
| New | +$426K | 0.24% | 72 |
|
2019
Q3 | – | Sell |
-20,888
| Closed | -$275K | – | 56 |
|
2019
Q2 | $275K | Buy |
+20,888
| New | +$275K | 0.19% | 127 |
|